AU Patent

AU2022262794A1 — Glycan modified nucleic acids, methods of preparation, and therapeutic uses

Assigned to Ganna Bio Inc · Expires 2023-11-02 · 3y expired

What this patent protects

The present disclosure relates to glyconucleic acids, such as glycoRNA and glycoDNA described herein. Provided are glycosylated ribonucleic acid (glycoRNA)-related methods and compositions.

USPTO Abstract

The present disclosure relates to glyconucleic acids, such as glycoRNA and glycoDNA described herein. Provided are glycosylated ribonucleic acid (glycoRNA)-related methods and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022262794A1
Jurisdiction
AU
Classification
—
Expires
2023-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Ganna Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.